The costs of carcinoma of the cervix

Jan Schneider, Leo B. Twiggs

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


Costs of cytology screening for carcinoma of the cervix are analyzed and the expenses of medical care compared in three theoretic populations: a) unscreened, b) screened for the first time and c) an ideal population screened repeatedly in the past. Cost estimates include diagnostic and therapeutic management of patients with positive reports and take into account the natural history of the disease. It is suggested that once all prevalent disease has been identified and treated, a reduced schedule in which patients are screened every third year is medically acceptable. Under these conditions, medical costs of carcinoma of the cervix become less than those in an unscreened population and there are no deaths from the disease.

Original languageEnglish (US)
Pages (from-to)851-859
Number of pages9
JournalObstetrics and gynecology
Issue number6
StatePublished - Dec 1972

ASJC Scopus subject areas

  • Obstetrics and Gynecology


Dive into the research topics of 'The costs of carcinoma of the cervix'. Together they form a unique fingerprint.

Cite this